StockIQ.techDanaher Corporation (DHR) Stock Analysis
Free AI-powered analysis and research for Danaher Corporation stock
Sector: Healthcare
DHR snapshot
Data as of 3 Nov 2026 close. Updated daily.
Danaher Corporation scores 61/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 86% of its 52-week range, up 8.1% over the past year. Latest reported figures show a profit margin of 16.9%, return on equity of 8.2% and revenue growth of +8.3%.
What is driving the score
- RSI Neutral: +5
- Strong Uptrend: +11
- MACD Bearish: -8
- High P/E (39.1): -10
- Good Profit Margin (16.9%): +5
- Strong Long-term Uptrend: +8
- Up Over 1 Year (+8.1%): +3
- Low Volume (0.2x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full DHR report
Danaher Corporation (DHR) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze DHR Now →📰 Latest Update
Bioprocess Automation Software Market Report 2026: Global Trends and Forecast to 2030 | Capitalize on 12.2% CAGR with Honeywell, Danaher, Siemens and Rockwell
Tue, November 3, 2026 at 2:18 PM UTC 4 min read
The global bioprocess automation software market is projected to grow from $3.07 billion in 2025 to $3.44 billion in 2026, with a compound annual growth rate (CAGR) of 12%. By 2030, the market is expected to reach $5.45 billion, driven by advancements in AI, cloud integration, and increased R&D investment. Key trends include the adoption of cloud-based platforms and real-time data analytics, as well as strategic partnerships and mergers, such as Danaher Corporation's acquisition of Genedata AG.